TrialBMC cancer2023

NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases.

Shin Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.